Arthur D. LittleArthur D. Little

Industries / Healthcare

“To tackle today’s healthcare issues, companies need insight, ingenuity and innovation.”

The healthcare industry is increasingly becoming resource-constrained.  A new generation of products and technological advances are making it challenging for companies to seek out the right investment opportunities for their business that satisfy both societal and shareholder needs. At Arthur D. Little, we help clients realize the full value of their medical innovations by leveraging our team’s talent and industry expertise in a way that challenges traditional thinking but leads to solutions that are competitive and sustainable.

Healthcare challenges

The global healthcare industry has transformed dramatically over the last decade. Advances in molecular biology coupled with new federal guidelines bring increased complexity to health-related business.  Over the next decade, we will see changes even more dramatic than in the last.  We believe a number of key market drivers will continue to shape the future of healthcare:

  • Rising need for healthcare services – An aging population brings with it the challenge of maintaining quality of life against an increasing prevalence of conditions such as diabetes, cancer and obesity. 
  • Escalating cost pressures – The need for global cost containment is forcing pharmaceutical firms to demonstrate value, creating demand for financial controls and operational efficiencies.   
  • Increasing technical advances – Advances in molecular biology offer not only the potential of new therapies – possibly tailored to the individual – but also offer the potential for the rejuvenation of the healthcare industry through the development of new business models and strategies.

Despite enormous strides that have been made in informing our knowledge, diagnosis, and treatment of disease, the healthcare industry must balance the need for new and effective therapies while addressing ever-higher regulatory and cost pressures.

The challenges are enormous!  The world expects the healthcare industry to deliver more innovative and effective products – despite costly R&D processes – for less.  If ever there was a time for innovative thinking, that time is now.

How we can help

Arthur D. Little has an established history of leadership in helping clients bridge the gap between strategy, management, and technology innovation.  Our proven tools, techniques, and methodologies combined with industry expertise uniquely position us to help medical technology, biopharmaceutical, and associate businesses around the world.  Our qualified team members have significant capabilities and experience in working with companies that will shape the direction and future of R&D, marketing, and strategy for pharmaceuticals, biotechnology, drug delivery, and fine chemicals.

Find out more about our Services.

Transforming Health Care

Strategy, Technology, and Innovation
Health care is embarking on one of the most dramatic transformations, both in terms of scientific innovation and policy. Scientific advances – systems biology, the decoding of the human genome, and biomarkers, to name a few – are coalescing in ways that are changing our fundamental understanding and knowledge of disease as well as how it is diagnosed and treated. This new era of personalized medicine is a direct result of the convergence of traditionally separate domains – biologics, pharmaceuticals, medical devices, diagnostics, biomarkers, and behavioral health interventions – that offer tremendous opportunities for market participants.

To download please login or register as a new user (PDF, 1.64 MB)